Daniel Geh

6PUBLICATIONS
25CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 03, 2023
Harnessing neutrophil plasticity for HCC immunotherapy.

Erik Ramon-Gil, Daniel Geh, Jack Leslie

|Apr 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapy.

Jack Leslie, John B G Mackey, Thomas Jamieson

|Apr 22, 2022
COVID-19 and liver cancer: lost patients and larger tumours.

Daniel Geh, Robyn Watson, Gourab Sen

|Jan 13, 2022
Neutrophils as potential therapeutic targets in hepatocellular carcinoma.

Daniel Geh, Jack Leslie, Rob Rumney

|Apr 15, 2021
NAFLD-Associated HCC: Progress and Opportunities.

Daniel Geh, Quentin M Anstee, Helen L Reeves

Pageof 1